Record Information |
---|
Version | 1.0 |
---|
Created at | 2020-12-09 02:10:04 UTC |
---|
Updated at | 2021-07-15 16:50:03 UTC |
---|
NP-MRD ID | NP0004747 |
---|
Secondary Accession Numbers | None |
---|
Natural Product Identification |
---|
Common Name | Azaserine |
---|
Provided By | NPAtlas |
---|
Description | Azaserine is a secondary metabolite. Secondary metabolites are metabolically or physiologically non-essential metabolites that may serve a role as defense or signalling molecules. In some cases they are simply molecules that arise from the incomplete metabolism of other secondary metabolites. Azaserine is found in Streptomyces sp. It was first documented in 1954 (PMID: 13132877). Based on a literature review a significant number of articles have been published on azaserine (PMID: 19136606) (PMID: 23101568) (PMID: 23301939) (PMID: 4951003). |
---|
Structure | [H]OC(=O)[C@@]([H])(N([H])[H])C([H])([H])OC(=O)C([H])=[N+]=[N-] InChI=1S/C5H7N3O4/c6-3(5(10)11)2-12-4(9)1-8-7/h1,3H,2,6H2,(H,10,11)/t3-/m0/s1 |
---|
Synonyms | Value | Source |
---|
Azaserina | ChEBI | Azaserinum | ChEBI | L-Azaserine | ChEBI | L-beta-(Diazoacetoxy)alanin | ChEBI | L-beta-(Diazoacetoxy)alanine | ChEBI | L-Serine diazoacetate | ChEBI | L-Serine diazoacetate ester | ChEBI | L-b-(Diazoacetoxy)alanin | Generator | L-Β-(diazoacetoxy)alanin | Generator | L-b-(Diazoacetoxy)alanine | Generator | L-Β-(diazoacetoxy)alanine | Generator | L-Serine diazoacetic acid | Generator | L-Serine diazoacetic acid ester | Generator | Azeserine | MeSH | O Diazoacetyl L serine | MeSH | O-Diazoacetyl-L-serine | MeSH |
|
---|
Chemical Formula | C5H7N3O4 |
---|
Average Mass | 173.1268 Da |
---|
Monoisotopic Mass | 173.04366 Da |
---|
IUPAC Name | (2S)-2-amino-3-{[2-(-lambda4,-lambda2-diazynylidene)acetyl]oxy}propanoic acid |
---|
Traditional Name | (2S)-2-amino-3-{[2-(-lambda4,-lambda2-diazynylidene)acetyl]oxy}propanoic acid |
---|
CAS Registry Number | Not Available |
---|
SMILES | N[C@@H](COC(=O)C=[N+]=[N-])C(O)=O |
---|
InChI Identifier | InChI=1S/C5H7N3O4/c6-3(5(10)11)2-12-4(9)1-8-7/h1,3H,2,6H2,(H,10,11)/t3-/m0/s1 |
---|
InChI Key | MZZGOOYMKKIOOX-VKHMYHEASA-N |
---|
Experimental Spectra |
---|
|
| Not Available | Predicted Spectra |
---|
|
| Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
---|
1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| Chemical Shift Submissions |
---|
|
| Not Available | Species |
---|
Species of Origin | |
---|
Chemical Taxonomy |
---|
Description | This compound belongs to the class of organic compounds known as l-alpha-amino acids. These are alpha amino acids which have the L-configuration of the alpha-carbon atom. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | L-alpha-amino acids |
---|
Alternative Parents | |
---|
Substituents | - L-alpha-amino acid
- Alpha-diazo ester
- Dicarboxylic acid or derivatives
- Carboxylic acid ester
- Amino acid
- Diazo compound
- Carboxylic acid
- Hydrocarbon derivative
- Organic zwitterion
- Organic nitrogen compound
- Primary amine
- Organooxygen compound
- Organonitrogen compound
- Primary aliphatic amine
- Organopnictogen compound
- Organic oxide
- Carbonyl group
- Amine
- Organic oxygen compound
- Aliphatic acyclic compound
|
---|
Molecular Framework | Aliphatic acyclic compounds |
---|
External Descriptors | |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Predicted Properties | |
---|
General References | - BARTZ QR, ELDER CC, FROHARDT RP, FUSARI SA, HASKELL TH, JOHANNESSEN DW, RYDER A: Isolation and characterization of azaserine. Nature. 1954 Jan 9;173(4393):72-3. doi: 10.1038/173072b0. [PubMed:13132877 ]
- Rajapakse AG, Ming XF, Carvas JM, Yang Z: The hexosamine biosynthesis inhibitor azaserine prevents endothelial inflammation and dysfunction under hyperglycemic condition through antioxidant effects. Am J Physiol Heart Circ Physiol. 2009 Mar;296(3):H815-22. doi: 10.1152/ajpheart.00756.2008. Epub 2009 Jan 9. [PubMed:19136606 ]
- Yener Y, Kalipci E, Oztas H, Aydin AD, Yildiz H: Possible neoplastic effects of acrylamide on rat exocrine pancreas. Biotech Histochem. 2013 Jan;88(1):47-53. doi: 10.3109/10520295.2012.733028. Epub 2012 Oct 29. [PubMed:23101568 ]
- Vibjerg Jensen R, Johnsen J, Buus Kristiansen S, Zachara NE, Botker HE: Ischemic preconditioning increases myocardial O-GlcNAc glycosylation. Scand Cardiovasc J. 2013 Jun;47(3):168-74. doi: 10.3109/14017431.2012.756984. Epub 2013 Jan 10. [PubMed:23301939 ]
- Protivinsky R: Azaserine. Antibiot Chemother (1971). 1971;17:95-100. doi: 10.1159/000392366. [PubMed:4951003 ]
|
---|